Symbol not found

:IPIX   00:00AM GMT
0.00
0.00 (0.00%)
Products

FDA Grants IND Approval For Phase 2 Clinical Trial Of Innovation Pharmaceuticals’ Brilacidin To Treat COVID-19

Published: 12/21/2020 12:17 GMT
(IPIX) - FDA Grants Ind Approval for Phase 2 Clinical Trial of Innovation Pharmaceuticals’ Brilacidin for Treating Covid-19.
Innovation Pharmaceuticals - Phase 2 Clinical Trial Expected to Enroll About 120 Patients With Moderate-to-severe Covid-19.